A groundbreaking clinical trial in Victoria, BC, is offering new hope to men battling prostate cancer. The ADAPT-25 trial, which has been running for five months, utilizes artificial intelligence and advanced radiation techniques to target cancerous cells with unprecedented precision. This innovative approach significantly reduces the impact on healthy tissue, transforming the treatment process from a lengthy, 40-visit regimen to a mere two-day procedure.
Abe Alexander, a radiation oncologist at BC Cancer's Victoria care center, explains, "In the past, curative radiation treatments have been a burden for men, requiring daily visits for several weeks. Now, we're pioneering a technology that can minimize the number of treatments and enhance their effectiveness."
The trial's primary goal is to combat the alarming statistic of over 4,000 prostate cancer diagnoses in the province each year. Alexander believes that ADAPT-25 will revolutionize treatment, "improving our ability to treat people, reducing side effects, and enhancing cure rates. It will also free up time, allowing patients to live their lives more fully."
So far, 10 men have enrolled in the trial, with another 10 in the enrollment process. One participant, Mike Miles, a 77-year-old cancer survivor, has already undergone two doses of the high-precision radiation. Miles shares his positive experience, noting that the treatments are mostly painless, with the only discomfort being the need to fill his bladder with water before the procedure.
The trial's impact on Miles' cancer is remarkable. His prostate-specific antigen level, a critical indicator of prostate cancer, dropped from 13 to 1.3, a significant improvement. Miles' cousin's husband, who received conventional radiation, developed leukemia, highlighting the potential life-saving benefits of ADAPT-25.
Alexander shares Miles' optimism, stating, "This technology will enable us to treat more men and optimize radiation treatment unit time. Our goal is to streamline the process, enhancing quality of life and outcomes for patients, while also allowing us to focus on other critical areas."
The trial will expand this summer to BC Cancer centers in Surrey and Abbotsford, making the treatment accessible to more families across the province. For more information about BC Cancer, visit bccancer.bc.ca.
